More on SRPT
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $61.51 |
|
|||
| Open | $61.37 | ||||
| 52 Wk High | $63.73 | ||||
| 52 Wk Low | $8.00 | ||||
| Day High | $61.93 | ||||
| Day Low | $60.87 | ||||
| P/E | N/A | ||||
| EPS | $-5.69 | ||||
| Volume | 97,313 | ||||
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
- Form ARS Sarepta Therapeutics, For: Dec 31
- Form DEFA14A Sarepta Therapeutics,
- Form DEF 14A Sarepta Therapeutics, For: Jun 05
- Sarepta Therapeutics (SRPT) PT Lowered to $160 at BMO Capital
- Sarepta Therapeutics to Announce First Quarter 2025 Financial Results
- Biotech stocks jump as Makary outlines FDA vision, RBC comments
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
- Sarepta Therapeutics (SRPT) PT Slashed at Piper Sandler Following Survey Results
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sarepta Therapeutics, Inc. - SRPT
Entities mentioned with SRPT
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Needham & Company | View Related Stories »
- PDUFA | View Related Stories »
- Robert W Baird | View Related Stories »
- Show More...
